date:Aug 13, 2014
and other stock-based compensation in Q2 2014 was $1,036,608. Excluding non-cash, share-based compensation expense, which is a non-GAAP measure, would have the effect of decreasing the Company's net loss for the three months ended June 28, 2014 to $616,534. As of June 28, 2014, cash, cash equivalents and marketable securities totaled approximately $1,280,627.
Frank Jaksch, Jr., CEO and co-founder of ChromaDex, commented, We are pleased to report that the increase in sales we experienced in Q1